ISDA

Entry Detail

PDB ID:

3R0I

Keywords:

OXIDOREDUCTASE/ANTIBIOTIC

Title:

IspC in complex with an N-methyl-substituted hydroxamic acid

Biological Source:

Source Organism:

Escherichia coli K-12

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2011-03-08

Release Date:

2011-09-07

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.10 Å

R-Value Free:

0.21

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:1-deoxy-D-xylulose 5-phosphate reductoisomerase
Chain IDs:A, B
Chain Length:410
Number of Molecules:2
Biological Source:Escherichia coli K-12

UniProt ID:P45568 Pfam ID:PF02670, PF08436, PF13288 EC:1.1.1.267

Ligand Molecules

C0K

Primary Citation

Reverse Fosmidomycin Derivatives against the Antimalarial Drug Target IspC (Dxr).

Behrendt, C.T, Kunfermann, A, Illarionova, V, Matheeussen, A, Pein, M.K, Grawert, T, Kaiser, J, Bacher, A, Eisenreich, W, Illarionov, B, Fischer, M, Maes, L, Groll, M, Kurz, T.Show

J.Med.Chem. 54 6796 6802 (2011)

PMID: 21866890 DOI: 10.1021/jm200694q

Abstact

Reverse hydroxamate-based inhibitors of IspC, a key enzyme of the non-mevalonate pathway of isoprenoid biosynthesis and a validated antimalarial target, were synthesized and biologically evaluated. The binding mode of one derivative in complex with EcIspC and a divalent metal ion was clarified by X-ray analysis. Pilot experiments have demonstrated in vivo potential.

Legend

Protein

Chemical

Disease

Primary Citation of related structures